Lv11
30 积分 2023-10-31 加入
Eltrombopag for the treatment of children with persistent and chronic immune thrombocytopenia (PETIT): a randomised, multicentre, placebo-controlled study
3小时前
待确认
Clinical aspects of platelet transfusions
22天前
已完结
[Management strategies for chronic liver disease-related thrombocytopenia]
22天前
已完结
Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With EGFR Variant
25天前
已完结
Multiple myeloma
29天前
已完结
Diagnosis and Management of Multiple Myeloma: A Review
1个月前
已完结
[Interpretation of treatment of relapsed/refractory multiple myeloma patients in the guidelines for the diagnosis and management of multiple myeloma in China(2022 revision)]
1个月前
已完结
Bispecific and multispecific antibodies in oncology: opportunities and challenges
1个月前
已完结
Multiple myeloma
1个月前
已完结
Odronextamab, a human CD20×CD3 bispecific antibody in patients with CD20-positive B-cell malignancies (ELM-1): results from the relapsed or refractory non-Hodgkin lymphoma cohort in a single-arm, multicentre, phase 1 trial
1个月前
已完结
皖公网安备34019202002308
